Dr Thomas Newsom-Davis, Consultant Medical Oncologist

Dr Thomas Newsom-Davis

Consultant Medical Oncologist

Book online
|

Dr Thomas Newsom-Davis BSc MBBS FRCP PhD

Consultant Medical Oncologist

BSc MBBS FRCP PhD

Dr Thomas Newsom-Davis

Consultant Medical Oncologist BSc MBBS FRCP PhD

Book online
|
BSc MBBS FRCP PhD
HCA-Healthcare-UK

Areas of expertise

  • Chemotherapy
  • Lung cancer
  • Mesothelioma
  • Thymus gland cancer
  • Primary lung tumours
HCA-Healthcare-UK

Recommendations for Dr Newsom-Davis

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byDr Neal Navani, Consultant in Respiratory Medicine

    Dr Tom Newsom Davis is a key opinion leader in thoracic oncology, providing an excellent clinical service and latest clinical trials.

  • byDr Neal Navani, Consultant in Respiratory Medicine

    Dr Tom Newsom Davis is a key opinion leader in thoracic oncology, providing an excellent clinical service and latest clinical trials.

  • Address

    About Dr Thomas Newsom-Davis

    GMC number: 4529260

    Year qualified: 1998

    Place of primary qualification: University of London

    Dr Thomas Newsom-Davis is a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies, with a particular focus on lung cancer and mesothelioma. In 2015, he was honoured with the Macmillan Innovation Excellence Award.

    Dr Newsom-Davis completed his medical training at University College and Middlesex School of Medicine, London, in 1998, achieving First Class honours for his BSc. He further specialised in medical oncology at Charing Cross and Hammersmith Hospitals and earned a PhD in tumour immunology. He was appointed to Chelsea and Westminster Hospital in 2010.

    Currently, Dr Newsom-Davis leads the lung cancer service at Chelsea and Westminster Hospital. He also serves as Vice Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, an organisation dedicated to supporting and educating thoracic oncology professionals across the United Kingdom. Additionally, he is Chair of the Harley Street Clinic lung cancer multidisciplinary team (MDT) and Chair of the HCA Healthcare UK Thoracic Oncology Board.

    Dr Newsom-Davis maintains an active clinical trial portfolio and has presented his research at both national and international conferences. He has been an invited lecturer for prestigious organisations such as the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association, and the Association of Cancer Physicians.

    His areas of expertise include immunotherapy, targeted therapy, and chemotherapy, with a focus on treating lung cancer and mesothelioma. Dr Newsom-Davis is committed to advancing the field of thoracic oncology and providing the highest standard of care to his patients.

    Areas of expertise

    • Lung Cancer
    • Mesothelioma
    • Acute Oncology
    • Other thoracic malignancies
    • Medical Oncology
    • Breast Cancers

    Professional memberships

    Royal College of Physicians
    General Medical Council

    Articles by Dr Thomas Newsom-Davis

    Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy

    Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy

    30-day mortality following initiation of immunotherapy for advanced stage lung cancer

    Emergency diagnosis of lung cancer: an international problem